138 related articles for article (PubMed ID: 14098188)
21. MAPLE SYRUP URINE DISEASE.
SNYDERMAN SE; HOLT LE
J Maine Med Assoc; 1964 Jan; 55():3-5. PubMed ID: 14109847
[No Abstract] [Full Text] [Related]
22. Metabolism of branched-chain amino acids in fibroblasts from patients with maple syrup urine disease and other abnormalities of branched-chain ketoacid dehydrogenase activity.
Yoshida I; Sweetman L; Nyhan WL
Pediatr Res; 1986 Feb; 20(2):169-74. PubMed ID: 3080729
[TBL] [Abstract][Full Text] [Related]
23. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
[TBL] [Abstract][Full Text] [Related]
24. Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease.
Dancis J; Hutzler J; Rokkones T
N Engl J Med; 1967 Jan; 276(2):84-9. PubMed ID: 6015521
[No Abstract] [Full Text] [Related]
25. Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency.
MACKENZIE DY; WOOLF LI
Br Med J; 1959 Jan; 1(5114):90-1. PubMed ID: 13608087
[No Abstract] [Full Text] [Related]
26. MAPLE SYRUP URINE DISEASE.
VOYCE MA; MONTGOMERY JN; LYNCH GA; BOWMAN JK
Br Med J; 1964 May; 1(5393):1293. PubMed ID: 14123637
[No Abstract] [Full Text] [Related]
27. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
[No Abstract] [Full Text] [Related]
28. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
[TBL] [Abstract][Full Text] [Related]
29. Maple syrup urine disease metabolites studies in cerebellum cultures.
Silberberg DH
J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
[No Abstract] [Full Text] [Related]
30. MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.
SNYDERMAN SE; NORTON PM; ROITMAN E; HOLT LE
Pediatrics; 1964 Oct; 34():454-72. PubMed ID: 14212461
[No Abstract] [Full Text] [Related]
31. [MAPLE SYRUP URINE DISEASE].
TIMMERMANS J
Maandschr Kindergeneeskd; 1963 Oct; 31():337-47. PubMed ID: 14100237
[No Abstract] [Full Text] [Related]
32. Effect of the branched-chain alpha-keto acids on pyruvate metabolism by homogenates of human brain.
Patel MS; Auerbach VH; Grover WD; Wilbur DO
J Neurochem; 1973 Jun; 20(6):1793-6. PubMed ID: 4719322
[No Abstract] [Full Text] [Related]
33. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
34. Leucine equivalency system in managing branched chain ketoaciduria.
Smith BA; Waisman HA
J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
[No Abstract] [Full Text] [Related]
35. TRANSAMINATION IN PERFUSED RAT LIVER.
BRISTOW DA; KERLY M
J Physiol; 1964 Mar; 170(2):318-27. PubMed ID: 14165168
[No Abstract] [Full Text] [Related]
36. MAPLE-SYRUP-URINE DISEASE. REPORT OF A CASE, WITH A PEDIGREE.
LONSDALE D; BARBER DH
N Engl J Med; 1964 Dec; 271():1338-41. PubMed ID: 14214646
[No Abstract] [Full Text] [Related]
37. Branched chain alpha-keto acid metabolism. I. Isolation, purification, and partial characterization of bovine liver alpha-ketoisocaproic:alpha-keto-beta-methylvaleric acid dehydrogenase.
Connelly JL; Danner DJ; Bowden JA
J Biol Chem; 1968 Mar; 243(6):1198-203. PubMed ID: 5689906
[No Abstract] [Full Text] [Related]
38. The influence of branched chain aminoacids and their ketoderivatives on renal gluconeogenesis.
Stumpf B; Kraus H; Kasten R
Curr Probl Clin Biochem; 1976; 6():51-64. PubMed ID: 11967
[TBL] [Abstract][Full Text] [Related]
39. [ACTIVATION OF ACELLULAR SYNTHESIS OF HEMOGLOBIN BY RIBONUCLEIC ACID. I. EFFECT OF TOTAL RIBONUCLEIC ACID ON RETICULOCYTES].
KRUH J; DREYFUS JC; SCHAPIRA G
Biochim Biophys Acta; 1964 Jun; 87():253-66. PubMed ID: 14192365
[No Abstract] [Full Text] [Related]
40. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
Sander C; Clotten R; Noetzel H; Wehinger H
Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
